NCT06033521
- Conditions
- Bone Demineralization, Bone Demineralization, Pathologic, Bone Diseases, +5 more
- Locations
-
- Pfizer South Korea Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Bone Demineralization, Pathologic. Study availability and eligibility vary by location and protocol.
NCT06033521
NCT03464266
NCT02426840
NCT00536276